AU2023218534A1 - Protein z variants binding thymic stromal lymphopoietin and their medical use - Google Patents

Protein z variants binding thymic stromal lymphopoietin and their medical use Download PDF

Info

Publication number
AU2023218534A1
AU2023218534A1 AU2023218534A AU2023218534A AU2023218534A1 AU 2023218534 A1 AU2023218534 A1 AU 2023218534A1 AU 2023218534 A AU2023218534 A AU 2023218534A AU 2023218534 A AU2023218534 A AU 2023218534A AU 2023218534 A1 AU2023218534 A1 AU 2023218534A1
Authority
AU
Australia
Prior art keywords
tslp
seq
sequence
binding polypeptide
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023218534A
Other languages
English (en)
Inventor
Anna EDVARDSSON
Lindvi GUDMUNDSDOTTER
Siavash KIJANI
Susanne KLINT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Affibody AB
Original Assignee
Affibody AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affibody AB filed Critical Affibody AB
Publication of AU2023218534A1 publication Critical patent/AU2023218534A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2023218534A 2022-02-08 2023-02-08 Protein z variants binding thymic stromal lymphopoietin and their medical use Pending AU2023218534A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22155646 2022-02-08
EP22155646.7 2022-02-08
PCT/EP2023/053030 WO2023152144A1 (en) 2022-02-08 2023-02-08 Protein z variants binding thymic stromal lymphopoietin and their medical use

Publications (1)

Publication Number Publication Date
AU2023218534A1 true AU2023218534A1 (en) 2024-07-11

Family

ID=80682629

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2023218534A Pending AU2023218534A1 (en) 2022-02-08 2023-02-08 Protein z variants binding thymic stromal lymphopoietin and their medical use

Country Status (10)

Country Link
EP (1) EP4476247A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025506381A (cg-RX-API-DMAC7.html)
KR (1) KR20240139058A (cg-RX-API-DMAC7.html)
CN (1) CN118632866A (cg-RX-API-DMAC7.html)
AR (1) AR128475A1 (cg-RX-API-DMAC7.html)
AU (1) AU2023218534A1 (cg-RX-API-DMAC7.html)
CA (1) CA3251231A1 (cg-RX-API-DMAC7.html)
IL (1) IL314458A (cg-RX-API-DMAC7.html)
MX (1) MX2024009732A (cg-RX-API-DMAC7.html)
WO (1) WO2023152144A1 (cg-RX-API-DMAC7.html)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE08786222T1 (de) 2007-07-31 2010-11-25 Affibody Ab Neue albuminbindende zusammensetzungen, verfahren und anwendungen
ES2373832T3 (es) 2007-12-19 2012-02-09 Affibody Ab Polipéptido derivado de proteína a y capaz de unirse a pdgf.
BR112013000452A2 (pt) 2010-07-09 2020-02-11 Affibody Ab Polipeptídeo de ligação de albumina, proteína de fusão ou conjugado, polinucleotídeo, método para produzir um polipeptídeo, composição, método para a preparação de uma composição, e, método para aumentar a solubilidade de um composto
US10155792B2 (en) 2012-09-25 2018-12-18 Affibody Ab Albumin binding polypeptide
WO2015189430A1 (en) 2014-06-13 2015-12-17 Affibody Ab New polypeptide
KR20240110106A (ko) * 2015-01-12 2024-07-12 애피바디 에이비 Il-17a-결합 폴리펩티드
CA3001264A1 (en) 2015-10-30 2017-05-04 Affibody Ab Pd-l1 binding polypeptide
WO2021089695A1 (en) * 2019-11-05 2021-05-14 Affibody Ab Polypeptides

Also Published As

Publication number Publication date
CN118632866A (zh) 2024-09-10
AR128475A1 (es) 2024-05-15
CA3251231A1 (en) 2023-08-17
WO2023152144A1 (en) 2023-08-17
KR20240139058A (ko) 2024-09-20
EP4476247A1 (en) 2024-12-18
MX2024009732A (es) 2024-08-19
IL314458A (en) 2024-09-01
JP2025506381A (ja) 2025-03-11

Similar Documents

Publication Publication Date Title
CN105555310B (zh) 一种提高蛋白血清半衰期的组合物和方法
EP2231707B1 (en) Anti mif antibodies
RU2749712C2 (ru) IL-17A-связывающие полипептиды
JP2013518853A (ja) 血清アルブミンと結合することが可能なペプチド並びにこれを含む化合物、構築物及びポリペプチド
KR20100098697A (ko) 폐 전달을 위한 조성물
US20250066451A1 (en) Il-ir-i binding polypeptide
WO2023035272A1 (zh) 一种il17抗体及其制备方法和应用
CN106488930B (zh) 新型多肽
CN121002060A (zh) 犬il-13的犬抗体
JP2026016388A (ja) 血清アルブミン結合ナノボディ組成物、及びその使用方法
CN116547006A (zh) 抗pd-l1纳米抗体及其应用
EP4476247A1 (en) Protein z variants binding thymic stromal lymphopoietin and their medical use
US20220389066A1 (en) Polypeptides
TWI840987B (zh) 單株抗體
WO2025223473A1 (zh) 抗gdf-15抗体及其应用
EP4665756A1 (en) Canine antibodies to canine il-4
CN121362254A (zh) 抗IL-4Rα单域抗体、其融合蛋白、药物组合物及用途
CN120623339A (zh) 一种抗人白细胞介素4受体的单域抗体及应用